Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis

Internal Medicine

Volumn 45, Issue 3, 2006, Pages 155-158

  Okubo, Kentaro ^a   Yoshizawa, Kaname ^a   Okiyama, Wataru ^a   Kontani, Kayoko ^a   Muto, Hidetomo ^a   Umemura, Takeji ^a   Ichijo, Tetsuya ^a   Matsumoto, Akihiko ^a   Tanaka, Eiji ^a   Hora, Kazuhiko ^b   Shimodaira, Sigetaka ^b   Kiyosawa, Kenyo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Granulocytapheresis; Interleukin 8; Neutrophil elastase; Severe alcoholic hepatitis; Ulinastatin

Indexed keywords

AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; METHYLPREDNISOLONE; SIVELESTAT; ULINASTATIN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG PULSE THERAPY; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRANULOCYTE; HUMAN; LATEX AGGLUTINATION TEST; LEUKAPHERESIS; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER DYSFUNCTION; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; PERIPHERAL EDEMA; PROGNOSIS; PROTHROMBIN TIME; TREATMENT OUTCOME;

ADULT; FEMALE; GLYCOPROTEINS; GRANULOCYTES; HEPATITIS, ALCOHOLIC; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; TRYPSIN INHIBITORS;

EID: 33644811037     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1456     Document Type: Article

References (30)

1. Levitsky J, Mailliard ME. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 24: 233-247, 2004.
2. Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe biopsy-proven alcoholic hepatitis treated by prednisolone: randomized trial, new cohort, and simulation. Gastroenterology 110: 1847-1853, 1996.
3. Ishii K, Furudera S, Kumashiro R, et al. Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis. Alcohol Alcohol Suppl 1B: 97-103, 1993.
4. Takahashi T, Kamimura T, Ichida F. Ultrastructural findings on polymorphonuclear leucoctye infiltration and acute hepatocellular damage in alcoholic hepatitis. Liver 7: 347-358, 1987.
5. Mathurin P, Mendenhall CL, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 36: 480-487, 2002.
6. Taieb J, Mathurin P, Elbim C, et al. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids. J Hepatol 32: 579-586, 2000.
7. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75: 193-199, 1978.
8. Carithers RL, Herlong WF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 110: 685-690, 1989.
9. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP Jr. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 61: 35-39, 2004 (Erratum in: Cytometry B Clin Cytom 61: 53, 2005).
10. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 27: 23-27, 2002.
11. Ishihara K, Yamaguchi Y, Okabe K, Ogawa M. Neutrophil elastase enhances macrophage production of chemokines in receptor-mediated reaction. Res Commun Mol Pathol Pharmacol 103: 139-147, 1999.
12. Saito H, Ishii H. Recent understanding of immunological aspects in alcoholic hepatitis. Hepatol Res 30: 193-198, 2004.
13. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112: 917-920, 1990.
14. Huang YS, Chan CY, Wu JC, Pai CH, Chao Y, Lee SD. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol 24: 377-384, 1996.
15. Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 18: 41-46, 1993.
16. Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 84: 449-453, 1991.
17. Fujimoto M, Uemura M, Nakatani Y, et al. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 24: 48S-54S, 2000.
18. Neuman MG. Cytokines - central factors in alcoholic liver disease. Alcohol Res Health 27: 307-316, 2003.
19. Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 15: 349-356, 2000.
20. Rosenberg HF, Gallin JI. Inflammation. In: Fundamental Immunology. 4th. Paul WE, Ed. Lippincott-Raven Publishers, Philadelphia, 1999: 1051-1066.
21. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045-1049, 1989.
22. Thornton AJ, Strieter RM, Lindley I, Baggiolini M, Kunkel SL. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 144: 2609-2613, 1990.
23. Zeiher BG, Matsuoka S, Kawabata K, Repine JE. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med 30 (5 Suppl): S281-287, 2002.
24. Shimoyama T, Sawada K, Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 16: 1-9, 2001.
25. Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Am J Gastroenterol 97: 2820-2828, 2002.
26. Kashiwagi N, Hirata I, Kasukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 2: 134-141, 1998.
27. Tsuji Y, Kumashiro R, Ishii K, et al. Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report. Alcohol Clin Exp Res 27 (8 Suppl): 26S-31S, 2003.
28. Yamaguchi Y, Ohshiro H, Nagao Y, et al. Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion. J Surg Res 94: 107-115, 2000.
29. Furukawa K, Kamimura T, Mahune Y, et al. Two patients with severe alcoholic hepatitis accompanied by hypercytokinemia and granulocytic hyperelastasemia, successfully treated by intravenous infusion of urinastarine (Miraclid). J Gastroenterol Hepatol 16: 575-580, 2001.
30. Nakamura T, Ushiyama C, Suzuki S, et al. Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purif 18: 50-54, 2000.